AZN
Astrazeneca Stock Analysis
AI Rating
- Quality9/10
- Growth↑ 7/10
- Value↓ 2/10
AZN Growth
- Revenue Y/Y↑ 9.90%
- EPS Y/Y↑ 33.93%
- FCF Y/Y↓ 1.42%
AZN Profitability
- Gross margin ↑ 81.70%
- EPS margin↑ 17.20%
- ROIC 5Y↑ 25.70%
AZN Dividends
- Dividend yield 4.60%
- Growth 3Y↑ 20.46%
- Payout ratio↑ 63%
AZN Risk
- Debt / Equity↓ 0.7
- Debt / FCF↓ 2.3
- Interest coverage↑ 8.4
Astrazeneca stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.